Exelixis Inc. buy Royal Bank of Canada
Start price
30.10.24
/
50%
€29.87
Target price
30.10.25
€31.30
Performance (%)
10.91%
End price
31.10.25
€33.13
Summary
This prediction ended on 31.10.25 with a price of €33.13. The prediction had a final performance of 10.91%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 3.503% | 3.503% | 28.927% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $34.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten